关于我们

About Us

美尚洁生物科技有限公司于2018年立项，目前总部位于江苏省张家港。我们专注于通过基因编辑以及合成生物技术，实现重组蛋白在各应用领域对传统动物源胶原蛋白的全面替代。始终秉承专业至上、诚信创新的理念，致力于推动皮肤再生的技术进步，树立了行业内不可撼动的领导者地位


Meishangjie Biotechnology Co., Ltd. was established in 2018 and is currently headquartered in Zhangjiagang, Jiangsu Province. We focus on using gene editing and synthetic biotechnology to achieve comprehensive substitution of recombinant proteins for traditional animal derived collagen in various application fields. Adhering to the concept of professionalism first, integrity and innovation, we are committed to promoting technological progress in skin regeneration and establishing an unshakable leadership position in the industry

      
      

2018年，成立美尚洁生物科技有限公司

2019-2021年，国内首创“重组纤连人胶化原蛋白”专利技术

2022年，二类医疗器械获批

2023-2024年，探索AI技术

2024年，在张家港建设 GMP管线 并且 AI 蛋白实现生产


In 2018, Meishangjie Biotechnology Co., Ltd. was established

From 2019 to 2021, China pioneered the patented technology of "recombinant fibronectin human collagen"

In 2022, Class II medical devices will be approved

Exploring AI technology in 2023-2024

In 2024, GMP pipelines will be built in Zhangjiagang and AI eggs will be self produced

如您遇到问题或对产品感兴趣，想要咨询等情况，请与我们联系，我们将在收到信息的第一时间与您进行交流。


If you encounter any problems or are interested in the product and would like to consult, please contact us. We will communicate with you as soon as we receive the information.